{
    "code": "02024874",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024874",
    "time": "2019-09-20 03:03:15",
    "許可證字號": "衛署藥輸字第024874號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/09\/02",
    "發證日期": "97\/09\/02",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202487408",
    "中文品名": "愛寧達注射劑 100 毫克",
    "英文品名": "Alimta for Injection 100mg",
    "適應症": "1.併用cisplatin是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第一線化療用藥。2.Alimta單一藥物是局部晚期或轉移性非小細胞肺癌(顯著麟狀細胞組織型除外)病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第二線治療用藥。4.與cisplatin併用於治療惡性肋膜間質細胞瘤。",
    "劑型": "243凍晶注射劑",
    "包裝": "100毫克小瓶裝 100支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "PEMETREXED DISODIUM HEPTAHYDRATE",
    "主製造廠": {
        "申請商名稱": "1411301100  台灣禮來股份有限公司",
        "申請商地址": "台北市復興北路３６５號１１樓",
        "主製造廠": "",
        "製造廠名稱": "FUS0073100  ELI LILLY AND COMPANY"
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1004002410",
            "成分名稱": "PEMETREXED DISODIUM HEPTAHYDRATE",
            "含量描述": "(eq. to Pemetrexed Free Acid 100mg)",
            "含量": "151.7000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Alimta-Final truth-ALM-0001-USPI-20171011+GOLD approved statement Dec08, Aug10_20Mar2019 v1 - Clean-108-08-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024874&Seq=009&Type=9"
        },
        {
            "title": "Alimta 100-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024874&Seq=001&Type=8"
        }
    ]
}